However, while PTEN silencing was able to further enhance the metastatic potential of “de-differentiated” colorectal cancer cells (HCT116 and CT26), it was not sufficient to confer metastatic properties to Caco-2/15 cells in vivo. The gene discussed is PTEN; the disease is colorectal cancer.